WEBSITECHANGES

Website Changes

---

12/16/2020

What Is a Cancer Commons Options Report?

---

12/15/2020

Novocure Announces National Reimbursement in Switzerland for Optune® in Combination With Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

---

12/14/2020

Musella Foundation awards another brain tumor research grant!

---

12/10/2020

Oblato Announces Discussion Outcome with FDA for Development of OKN-007 for Diffuse Intrinsic Pontine Glioma

---

12/10/2020

`The Surgeon`s Cut` Review: Netflix docuseries is a moving look at pioneering doctors who overcame obstacles

---

12/10/2020

Kazia Therapeutics’ (ASX:KZA) brain cancer drug selected for international study

---

12/10/2020

PLUS THERAPEUTICS EXPANDS RESPECT™ CLINICAL TRIAL TO MD ANDERSON CANCER CENTER

---

12/10/2020

TVAX Biomedical announces major advancements in potential Glioblastoma cure

---

12/06/2020

Why Study Sexual Health in Patients With Lung Cancer?

---

12/06/2020

New Expanded Access Program for MAPK-Pathway Altered Cancers

---

12/01/2020

Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

---

11/30/2020

OncoSynergy Opens Enrollment for Clinical Trial of New Cancer Antibody Therapy, OS2966, in Patients with Recurrent Glioblastoma

---

11/30/2020

Al Musella`s Thoughts on the SNO 2020 Conference!

---

11/26/2020

2020 UCLA Brain Tumor Virtual Conference

---

11/23/2020

New version of NCCN Guidelines for CNS Cancers

---

11/23/2020

Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial

---

11/22/2020

Brain tumor patients get to interview celebrities!

---

11/22/2020

INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting

---

11/22/2020

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

---

11/22/2020

DNAtrix Announces Positive Data from Phase 2 CAPTIVE (KEYNOTE-192) Study with DNX-2401 in Patients with Recurrent Glioblastoma Highlighted in an Oral Late-Breaking Presentation During Society for Neuro-oncology (SNO) Annual Meeting

---

11/20/2020

PLUS THERAPEUTICS ANNOUNCES POSITIVE INTERIM DATA FROM RESPECT™ PHASE 1 CLINICAL TRIAL IN RECURRENT GLIOBLASTOMA

---

11/19/2020

Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting

---

11/19/2020

NX Development Corp. (NXDC) Launches Gleolan (aminolevulinic acid HCl) Meningioma Phase III Clinical Trial (NXDC-MEN-301)

---

11/17/2020

xCures launches xACCESS - A new module in their AI-assisted clinical platform

---

11/17/2020

PLUS THERAPEUTICS ANNOUNCES WEBINAR TO PRESENT RESPECT™ GLIOBLASTOMA CLINICAL TRIAL UPDATE

---